UCF Researchers Develop Multiplex Biosensor for HIV and Hepatitis Detection
Electrochemical biosensor aims to simultaneously detect HIV, Hepatitis B, and Hepatitis C in resource-limited settings using RNA-level identification.
Electrochemical biosensor aims to simultaneously detect HIV, Hepatitis B, and Hepatitis C in resource-limited settings using RNA-level identification.
WHO has granted Cepheid’s Xpert Mpox test Emergency Use Listing, enabling rapid, point-of-care mpox detection to support outbreak management.
QuidelOrtho received FDA 510(k) clearance for its VITROS syphilis assay, expanding its test portfolio to address the syphilis epidemic.
Researchers developed a new lab test to detect intact HIV infections with African strains, crucial for advancing global HIV cure efforts.
Read MoreSyphilis cases are rising globally, yet many Americans remain unaware of its symptoms and treatment options.
Read MoreThere has been significant rise in sexually transmitted infections (STIs), underscoring the need for improved STI testing and diagnostics.
Read MoreSyphilis cases in Tennessee have surged among women, due to insufficient prenatal testing and treatment, compounded by a penicillin shortage.
Read MoreTestmate Health secured $6 million in seed funding to develop an OTC self-test for STIs, initially targeting chlamydia and gonorrhea.
Read MoreScout received funding to develop a test to detect and differentiate between Neisseria gonorrhoeae and Chlamydia trachomatis quickly.
Read MoreTo increase the amount of syphilis testing, labs need to remove moral judgement and acknowledge the STI as just another infection.
Read MoreTo stem the tide of the STI epidemic, health care must work together through education, prevention, screening, diagnosis, and treatment.
Read MoreThee American Medical Association launched a new toolkit to help increase screenings for HIV, STIs, viral hepatitis and latent tuberculosis.
Read MoreEmphasizing the healthcare disparities through increased testing for effective prevention of congenital syphilis needs addressing.
Read MoreNOWDiagnostics submitted a De Novo Classification Request to the U.S. FDA for the company’s First to Know at-home syphilis test.
Read MoreThe FDA is providing this information to educate health care providers and clinical laboratory staff and reduce the risk of false results.
Read MoreThe company began commercial shipments as part of the initial purchase order for 2.5 million tests, with further shipments scheduled.
Read MoreQuidelOrtho received 510(K) clearance from the FDA for its innovative Savanna PCR platform and Savanna HSV 1+2/VZV in vitro diagnostic test
Read MoreHIV can hide in the body for many years before symptoms appear. Meanwhile, it is quietly killing part of the immune system.Â
Read More